Assignee
J PHARMA CO LTD
JP·3 granted patents·6 pending applications·2 citations·filing 2014–2024
Top patents by PatentIndex Score
9 records- 0169US10172835B2Anticancer agent compositionJ PHARMA CO LTD·Filed 2014·Granted Jan 8, 2019·2 cites·1 claims
- 0260US2021231668A1Kit and method for determining prostate cancer malignancyJ PHARMA CO LTD·Filed 2021·Application pending·0 cites
- 0359US2022288035A1A pharmaceutical composition for treating cancer used for a patient having specific genetic markerJ PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 0456US2025041281A1Method of treating biliary tract cancerJ PHARMA CO LTD·Filed 2024·Application pending·0 cites
- 0552US11899019B2Method for predicting efficacy of anti-PD-1 antibody or anti-PD-L1 antibody therapy, method for evaluating cancer grade, and method for enhancing efficacy of anti-PD-1 antibody or anti-PD-L1 antibody therapyJ PHARMA CO LTD·Filed 2018·Granted Feb 13, 2024·0 cites·1 claims
- 0652US2022288036A1A pharmaceutical composition used for a patient having specific genetic markerJ PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 0743US12458628B2Cancer therapeuticJ PHARMA CO LTD·Filed 2018·Granted Nov 4, 2025·0 cites·11 claims
- 0841US2019227070A1Kit and method for determining prostate cancer malignancyJ PHARMA CO LTD·Filed 2016·Application pending·0 cites
- 0933US2016370379A1Blood-based biomarker for cancerJ-PHARMA CO LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when J PHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →